Amwell® to report fourth quarter and full year 2024 operating results
- 79
BOSTON, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in digital care, will report fourth quarter 2024 operating results after stock market trading hours on Wednesday, Feb. 12.
Following the distribution of the earnings alert via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the company's operating results and provide a general business update.
The full earnings report and the live audio webcast can be accessed by visiting the Investors section of the company's website. A webcast replay of the call will be available at investors.amwell.com for approximately 90 days.
About Amwell
Amwell is a leading hybrid care, delivery enablement platform in the United States and globally, connecting and enabling providers, payers, patients, and innovators to deliver greater access to more affordable, higher quality care. Amwell believes that hybrid care delivery will transform healthcare. We offer a single, comprehensive platform to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. With nearly two decades of experience, Amwell powers the digital care of more than 50 health plans, which collectively represent more than 100 million covered lives, and many of the nation’s largest health systems. For more information, please visit https://business.amwell.com/.
©2025 American Well Corporation. All rights reserved. Amwell®, SilverCloud®, Amwell Converge™, Carepoint™ and the Amwell Logo are registered trademarks of American Well Corporation.
Investors: Sue Dooley 415.602.9167 [email protected] Media: Angela Vogen [email protected]
GlobeNewswire es una de las redes de distribución de noticias por cable más grandes del mundo, que se especializa en la entrega de comunicados de prensa corporativos, divulgaciones financieras y contenido multimedia a los medios, inversionistas y lectores de todo el mundo.
- La FDA advierte a los pacientes sobre la posibilidad de no recibir alertas de seguridad importantes debido a la configuración del teléfono cuando usan dispositivos para la diabetes compatibles con teléfonos inteligentes
- Rimini Street celebra el 10° aniversario de su fundación corporativa con una donación benéfica RMNI LOVE de $100,000
- ACON Investments completa la venta de Vitalis
- Glenmorgan Investments va camino de alcanzar los 7.000 millones de dólares en activos gestionados
- Pearson lanza tutor digital de idiomas en América Latina para enfrentar desafíos del mercado laboral
- Abierto el plazo de inscripción para World of Coffee 2025 en Ginebra